rofecoxib has been researched along with Cirrhosis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Impact of rofecoxib on progressing of pancreatic fibrous changes in the rats in experimental chronic pancreatitis, caused by L-arginine, was studied up." | 7.79 | [New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats]. ( Berehova, TV; Falalieieva, TM; Petrushenko, VV; Sukhodolia, SA, 2013) |
| "Impact of rofecoxib on progressing of pancreatic fibrous changes in the rats in experimental chronic pancreatitis, caused by L-arginine, was studied up." | 3.79 | [New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats]. ( Berehova, TV; Falalieieva, TM; Petrushenko, VV; Sukhodolia, SA, 2013) |
| "Compared with the spontaneous development of inflammatory injury and fibrosis in WBN/Kob control rats, animals treated with rofecoxib exhibited a significant reduction and delay (p<0." | 3.73 | A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. ( Bimmler, D; Fortunato, F; Graf, R; Perren, A; Reding, T; Storni, F; Sun, LK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrushenko, VV | 1 |
| Sukhodolia, SA | 1 |
| Falalieieva, TM | 1 |
| Berehova, TV | 1 |
| Wang, BH | 1 |
| Bertucci, MC | 1 |
| Ma, JY | 1 |
| Adrahtas, A | 1 |
| Cheung, RY | 1 |
| Krum, H | 1 |
| Månsson, LE | 1 |
| Montero, M | 1 |
| Zarepour, M | 1 |
| Bergstrom, KS | 1 |
| Ma, C | 1 |
| Huang, T | 1 |
| Man, C | 1 |
| Grassl, GA | 1 |
| Vallance, BA | 1 |
| LaPointe, MC | 1 |
| Mendez, M | 1 |
| Leung, A | 1 |
| Tao, Z | 1 |
| Yang, XP | 1 |
| Reding, T | 1 |
| Bimmler, D | 1 |
| Perren, A | 1 |
| Sun, LK | 1 |
| Fortunato, F | 1 |
| Storni, F | 1 |
| Graf, R | 1 |
| Ofran, Y | 1 |
| Bursztyn, M | 1 |
| Ackerman, Z | 1 |
6 other studies available for rofecoxib and Cirrhosis
| Article | Year |
|---|---|
[New approach for treatment of chronic pancreatitis, caused by L-arginine, in rats].
Topics: Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Cyclooxygenase 2 Inhibitors; F | 2013 |
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Car | 2010 |
MyD88 signaling promotes both mucosal homeostatic and fibrotic responses during Salmonella-induced colitis.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enterocolitis; Fibrosis; Intestinal Mucosa; | 2012 |
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
Topics: Animals; Cardiomegaly; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhib | 2004 |
A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.
Topics: Animals; Cell Movement; Chemotactic Factors; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 In | 2006 |
Rofecoxib-induced renal dysfunction in a patient with compensated cirrhosis and heart failure.
Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Fibrosis; Heart Fa | 2001 |